{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:18:38Z","timestamp":1791346718317,"version":"4.3.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES:<\/jats:title>\n                    <jats:p>The release of neutrophil extracellular traps is a key immune host defense mechanism that can contribute to organ damage during sepsis if excessive. We evaluated presentation H3.1 nucleosome levels in patients with sepsis, septic shock, and sepsis-associated acute kidney injury (AKI). We sought to determine if plasma H3.1 nucleosome levels could serve as predictive biomarkers for both renal replacement therapy (RRT) requirements and 28-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DESIGN:<\/jats:title>\n                    <jats:p>A secondary analysis of prospectively collected samples from the large multicenter Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients with Severe Sepsis or Septic Shock (SISPCT) trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SETTING:<\/jats:title>\n                    <jats:p>Patients from 33 ICUs in Germany recruited between November 6, 2009, and June 6, 2013, including a 90-day follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients:<\/jats:title>\n                    <jats:p>A total of 971 patients with complete data on plasma H3.1 admission levels with sepsis and septic shock, and 927 patients with complete data on RRT requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>INTERVENTIONS:<\/jats:title>\n                    <jats:p>None.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n                    <jats:p>\n                      We evaluated associations between H3.1 levels and mortality and the time to commencement of RRT using multivariable Cox regression. A total of 443 patients (45.6%) presented with sepsis, and 520 patients (53.6%) had septic shock. Admission H3.1 levels were higher in patients with septic shock than sepsis (median, 921.84 vs. 432.71\u2009ng\/mL;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). In a multivariable analysis for 28-day mortality, a one unit increase in log10 H3.1 levels was associated with a 48% increase in 28-day mortality (adjusted hazard ratio [HR], 1.48, 95% CI, 1.07\u20132.04;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.02). Plasma H3.1 was also higher in patients with stage 3 AKI requiring RRT with septic shock vs. sepsis (1832 vs. 801.4\u2009ng\/mL;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.01). In a multivariable Cox regression controlling for maximum lactate, procalcitonin, and C-reactive protein levels, plasma H3.1 levels were significantly higher in patients who developed AKI requiring RRT when compared with patients who did not develop AKI, with one log10 increase of H3.1 increasing the risk of 28-day RRT by 80% (adjusted HR, 1.8; 95% CI, 1.34\u20132.40;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Elevated levels of H3.1 nucleosomes at admission are associated with mortality and AKI requiring RRT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration:<\/jats:title>\n                    <jats:p>The trial was registered in clinicaltrials.gov, identifier: NCT00832039.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ccm.0000000000007270","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:10:20Z","timestamp":1785766220000},"page":"2567-2578","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["H3.1 Nucleosomes to Predict Renal Replacement Therapy and Mortality in Sepsis\u2014A Secondary Analysis of the SISPCT Randomized Control Trial"],"prefix":"10.1097","volume":"54","author":[{"given":"Caroline","family":"Neumann","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Bloos","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teddy Tun Win","family":"Hla","sequence":"additional","affiliation":[{"name":"Critical Care Department, Guy\u2019s and St Thomas NHS Foundation Trust, London, United Kingdom."},{"name":"Institute of Health Informatics, University College London, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bygott","sequence":"additional","affiliation":[{"name":"Volition Diagnostics UK Ltd, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bogatsch","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics and Epidemiology, Clinical Trial Centre, Leipzig University, Leipzig, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kiehntopf","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"B\u00f6rner","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry and Laboratory Diagnostics, Jena University Hospital, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian T","family":"Press","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany."},{"name":"Center for Sepsis Control and Care, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany."},{"name":"Medical Faculty, Friedrich Schiller University Jena, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Retter","sequence":"additional","affiliation":[{"name":"Critical Care Department, Guy\u2019s and St Thomas NHS Foundation Trust, London, United Kingdom."},{"name":"Volition Diagnostics UK Ltd, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the SepNet Critical Care Trials Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"R1-20261006","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: Analysis for the Global Burden of Disease Study.","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"R2-20261006","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3).","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"R3-20261006","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00134-023-07138-0","article-title":"Sepsis-associated acute kidney injury in the intensive care unit: Incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study.","volume":"49","author":"White","year":"2023","journal-title":"Intensive Care Med"},{"key":"R4-20261006","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2019.05.026","article-title":"Acute kidney injury from sepsis: Current concepts, epidemiology, pathophysiology, prevention and treatment.","volume":"96","author":"Peerapornratana","year":"2019","journal-title":"Kidney Int"},{"key":"R5-20261006","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41581-023-00683-3","article-title":"Sepsis-associated acute kidney injury: Consensus report of the 28th acute disease quality initiative workgroup.","volume":"19","author":"Zarbock","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"R6-20261006","doi-asserted-by":"crossref","first-page":"R222","DOI":"10.1186\/cc11868","article-title":"Patterns and early evolution of organ failure in the intensive care unit and their relation to outcome.","volume":"16","author":"Sakr","year":"2012","journal-title":"Crit Care"},{"key":"R7-20261006","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: The multinational AKI-EPI study.","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"R8-20261006","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00134-017-4809-x","article-title":"Renal recovery after acute kidney injury.","volume":"43","author":"Forni","year":"2017","journal-title":"Intensive Care Med"},{"key":"R9-20261006","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria.","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"R10-20261006","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1016\/j.jtha.2024.05.028","article-title":"Rapid high-throughput method for investigating physiological regulation of neutrophil extracellular trap formation.","volume":"22","author":"Zukas","year":"2024","journal-title":"J Thromb Haemost"},{"key":"R11-20261006","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1182\/blood-2023-178100","article-title":"Understanding netosis priming and induction through nucleosome changes and real-time monitoring in isolated neutrophils and in an ex-vivo model.","volume":"142","author":"Cayford","year":"2023","journal-title":"Blood"},{"key":"R12-20261006","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1164\/rccm.201811-2111OC","article-title":"A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients.","volume":"200","author":"Abrams","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R13-20261006","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1097\/CCM.0000000000001162","article-title":"Circulating histones are major mediators of cardiac injury in patients with sepsis.","volume":"43","author":"Alhamdi","year":"2015","journal-title":"Crit Care Med"},{"key":"R14-20261006","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nm.2053","article-title":"Extracellular histones are major mediators of death in sepsis.","volume":"15","author":"Xu","year":"2009","journal-title":"Nat Med"},{"key":"R15-20261006","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1097\/CCM.0b013e318265695f","article-title":"Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C.","volume":"40","author":"Zeerleder","year":"2012","journal-title":"Crit Care Med"},{"key":"R16-20261006","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1681\/ASN.2011111077","article-title":"Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4.","volume":"23","author":"Allam","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R17-20261006","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1681\/ASN.2016080925","article-title":"Histones and neutrophil extracellular traps enhance tubular necrosis and remote organ injury in ischemic AKI.","volume":"28","author":"Nakazawa","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R18-20261006","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s13054-014-0543-8","article-title":"Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation.","volume":"18","author":"Ekaney","year":"2014","journal-title":"Crit Care"},{"key":"R19-20261006","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jamainternmed.2016.2514","article-title":"Effect of sodium selenite administration and procalcitonin-guided therapy on mortality in patients with severe sepsis or septic shock: A randomized clinical trial.","volume":"176","author":"Bloos","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R20-20261006","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury.","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"R21-20261006","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials.","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"R22-20261006","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s10753-020-01294-x","article-title":"The role of neutrophil NETosis in organ injury: Novel inflammatory cell death mechanisms.","volume":"43","author":"Cahilog","year":"2020","journal-title":"Inflammation"},{"key":"R23-20261006","doi-asserted-by":"crossref","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: A predominant role of histones.","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS One"},{"key":"R24-20261006","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41420-023-01614-8","article-title":"Neutrophil extracellular traps contribute to immunothrombosis formation via the STING pathway in sepsis-associated lung injury.","volume":"9","author":"Shuainan","year":"2023","journal-title":"Cell Death Discov"},{"key":"R25-20261006","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","article-title":"Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients.","volume":"127","author":"Claushuis","year":"2016","journal-title":"Blood"},{"key":"R26-20261006","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13613-023-01204-y","article-title":"Association of pronounced elevation of NET formation and nucleosome biomarkers with mortality in patients with septic shock.","volume":"13","author":"Haem Rahimi","year":"2023","journal-title":"Ann Intensive Care"},{"key":"R27-20261006","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00134-017-4715-2","article-title":"Ten shortcomings of the current definition of AKI.","volume":"43","author":"Schetz","year":"2017","journal-title":"Intensive Care Med"},{"key":"R28-20261006","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00134-018-5126-8","article-title":"Biomarkers for prediction of renal replacement therapy in acute kidney injury: A systematic review and meta-analysis.","volume":"44","author":"Klein","year":"2018","journal-title":"Intensive Care Med"},{"key":"R29-20261006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury.","volume":"383","year":"2020","journal-title":"N Engl J Med"},{"key":"R30-20261006","doi-asserted-by":"crossref","first-page":"1496966","DOI":"10.3389\/fmed.2024.1496966","article-title":"Plasma neutrophil extracellular traps in patients with sepsis-induced acute kidney injury serve as a new biomarker to predict 28-day survival outcomes of disease.","volume":"11","author":"He","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R31-20261006","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.3390\/ijms20205238","article-title":"The predictive role of the biomarker kidney molecule-1 (KIM-1) in Acute Kidney Injury (AKI) cisplatin-induced nephrotoxicity.","volume":"20","author":"Tanase","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R32-20261006","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21470\/1678-9741-2018-0212","article-title":"Acute kidney injury after cardiac surgery: Risk factors and novel biomarkers.","volume":"34","author":"Yuan","year":"2019","journal-title":"Braz J Cardiovasc Surg"},{"key":"R33-20261006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-021-03618-1","article-title":"External validation of urinary C-C motif chemokine ligand 14 (CCL14) for prediction of persistent acute kidney injury.","volume":"25","author":"Bagshaw","year":"2021","journal-title":"Crit Care"},{"key":"R34-20261006","doi-asserted-by":"crossref","first-page":"e93460","DOI":"10.1371\/journal.pone.0093460","article-title":"Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.","volume":"9","author":"Meersch","year":"2014","journal-title":"PLoS One"},{"key":"R35-20261006","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1373\/clinchem.2018.288068","article-title":"Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock.","volume":"64","author":"Caironi","year":"2018","journal-title":"Clin Chem"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:25Z","timestamp":1791302485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/CCM.0000000000007270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000007270","relation":{},"ISSN":["0090-3493","1530-0293"],"issn-type":[{"value":"0090-3493","type":"print"},{"value":"1530-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}